| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 105, 1053-1060, Copyright © 1994 by American College of Chest Physicians
ARTICLES |
JP Renston, AF DiMarco and GS Supinski
Department of Medicine, MetroHealth Medical Center, Cleveland 44109- 1998.
To more systematically evaluate the effect of respiratory muscle rest on indices of ventilatory function, nine outpatients with stable, severe COPD were treated with nasal pressure-support ventilation delivered via a nasal ventilatory support system (BiPAP, Respironics, Inc) for 2 h a day for 5 consecutive days. An additional eight control patients were treated with sham-BiPAP. Maximum inspiratory pressure (MIP), maximum expiratory pressure (MEP), maximum voluntary ventilation (MVV), arterial blood gas values, Borg dyspnea score, dyspnea- associated functional impairment scales, and distance walked in 6 min were measured in subjects prior to and following the week-long trial. Nasal BiPAP produced a 66.3 +/- 6 percent reduction in peak integrated diaphragmatic electromyographic (EMG) activity. There were no statistically significant changes in MIP, MEP, MVV, arterial pH, PaCO2, or PaO2 or in objective measures of functional impairment from dyspnea in either group after ventilator or sham treatment. However, nasal BiPAP reduced the Borg category score during resting, spontaneous breathing from 2.0 +/- 0.4 to 0.7 +/- 0.3 (p < 0.01) after 5 days of treatment. In contrast, sham BiPAP-treated patients had no change in their dyspnea score, which was 1.8 +/- 0.4 and 1.3 +/- 0.4 before and after sham treatment, respectively. Nasal BiPAP also increased distance walked in 6 min from 780 +/- 155 to 888 +/- 151 ft (p < 0.01) (23,400 +/- 4,650 to 26,640 +/- 4,530 cm) (p < 0.01), whereas sham-BiPAP had no effect (768 +/- 96 and 762 +/- 106 ft [23,040 +/- 2,880 and 22,860 +/- 3,180 cm]) before and after sham treatment, respectively). In conclusion, these results indicate that nasal pressure-support ventilation, delivered via nasal BiPAP, improves exercise capacity and reduces dyspnea over the short term in selected outpatients with stable severe COPD. Whether such short-term improvement can be sustained merits further study.
This article has been cited by other articles:
|
|
 |
|
  O. Diaz, P. Begin, M. Andresen, M. E. Prieto, C. Castillo, J. Jorquera, and C. Lisboa Physiological and clinical effects of diurnal noninvasive ventilation in hypercapnic COPD Eur. Respir. J., December 1, 2005; 26(6): 1016 - 1023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Wijkstra, Y. Lacasse, G. H. Guyatt, C. Casanova, P. C. Gay, J. Meecham Jones, and R. S. Goldstein A Meta-analysis of Nocturnal Noninvasive Positive Pressure Ventilation in Patients With Stable COPD Chest, July 1, 2003; 124(1): 337 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Diaz, P. Begin, B. Torrealba, E. Jover, and C. Lisboa Effects of noninvasive ventilation on lung hyperinflation in stable hypercapnic COPD Eur. Respir. J., December 1, 2002; 20(6): 1490 - 1498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.A. Wedzicha and J-F. Muir Noninvasive ventilation in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis Eur. Respir. J., September 1, 2002; 20(3): 777 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Casanova, B. R. Celli, L. Tost, E. Soriano, J. Abreu, V. Velasco, and F. Santolaria Long-term Controlled Trial of Nocturnal Nasal Positive Pressure Ventilation in Patients With Severe COPD Chest, December 1, 2000; 118(6): 1582 - 1590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sinuff, D. Cook, J. Randall, and C. Allen Noninvasive positive-pressure ventilation: a utilization review of use in a teaching hospital Can. Med. Assoc. J., October 1, 2000; 163(8): 969 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. T. McNicholas Impact of Sleep in COPD Chest, February 1, 2000; 117(2_suppl): 48S - 53S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Criner, K. Brennan, J. M. Travaline, and D. Kreimer Efficacy and Compliance With Noninvasive Positive Pressure Ventilation in Patients With Chronic Respiratory Failure Chest, September 1, 1999; 116(3): 667 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Meek Dyspnea . Mechanisms, Assessment, and Management: A Consensus Statement Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 321 - 340. [Full Text]
|
|
|
|
 |
|
 R. E. Hillberg and D. C. Johnson Noninvasive Ventilation N. Engl. J. Med., December 11, 1997; 337(24): 1746 - 1752. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
